James Moore: Drug makers in a fix as new treatments fall short
Outlook: Ouch. TC-5214 has tipped up. AstraZeneca is facing up to the failure of yet another drug from its already limited looking pipeline of new treatments.
The experimental antidepressant has failed its latest clinical trials and will be dropped at a $50m (£31m) cost. Disorders of the brain are proving tough to treat, largely because our understanding of that rather crucial organ is not really at a sufficiently high level to allow drug makers to develop remedies for its many maladies.
And it isn't just the brain. The same is true in many fields of medicine and so there will be many more TC-5214s to come. As patents run out and generic drug makers get to work on their reliable earners, the giants of the pharmaceutical world are having to grapple with a number of unpleasant dilemmas. Research is becoming increasingly risky and expensive and that is not a message that shareholders like to hear.
Astra is not alone in having a weak-looking pipeline and finding a cure for this isn't going to be easy.
So far the only potential treatment the industry's leaders have found is buying up rivals. But that is no magic bullet. Not only is it extraordinarily costly, it also usually comes with any number of unforeseen and nasty side-effects.
- 1 What if 35 Palestinians had died, and 800 Israelis?
- 2 Disney heiress Abigail disowns her share of family profits in West Bank company
- 3 The secret report that helps Israel hide facts
- 4 'Women should not laugh in public,' says Turkey's Deputy Prime Minister in morality speech
- 5 Ross Burden dead: MasterChef and Ready Steady Cook star dies at age 45 after suffering from cancer
A former custard factory, a Midlands bog and a Leeds cemetery all included in top 50 hidden spots in the UK
Disney heiress Abigail disowns her share of family profits in West Bank company
'Women should not laugh in public,' says Turkey's Deputy Prime Minister in morality speech
Richard Dawkins tweets: 'Date rape is bad, stranger rape is worse'
Ross Burden dead: MasterChef and Ready Steady Cook star dies at age 45 after suffering from cancer
The secret report that helps Israel hide facts
Woman and two children killed by mob in riots over 'blasphemous' Facebook post in Pakistan
A day in the life of Vladimir Putin: The dictator in his labyrinth
Putin is 'thuggish, dishonest and reckless', says British ambassador to US
Boozy, ignorant, intolerant, but very polite – Britain as others see us
A new Russian revolution: The cracks are starting to appear in Putin’s Kremlin power bloc
- < Previous
- Next >
iJobs Money & Business
£350 - £400 per day + competitive: Orgtel: Senior Analyst, ALM Data, Halifax, ...
£500 - £600 per day: Orgtel: Java developer - Banking - London - Up to £600/d...
£400 per day + competitive: Orgtel: Liquidity Reporting - Basel III - LCR - Ba...
Negotiable: Harrington Starr: Client Services Associate (Microsoft Office, Ana...